ABSTRACT:Zonampanel monohydrate ([2,3-dioxo-7-(1H-imidazol-1-yl)-6-nitro-1,2,3,4-tetrahydro-1-quinoxalinyl] acetic acid monohydrate, YM872) is a novel ␣-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist. In humans, almost all administered zonampanel is excreted in the urine unchanged. Furthermore, zonampanel is transported by human organic anion transporter (OAT) 1, and OAT3 but not by OAT2, suggesting the contribution of OATs to renal excretion. In rats also, zonampanel is predominantly eliminated via urine but partly also via bile as the unchanged form. In this study, the molecular mechanism of the excretion of zonampanel was elucidated using cells expressing rat Oat1, Oat2, and Oat3. Zonampanel monohydrate (YM872) (Fig. 1) is a selective antagonist of the glutamate receptor subtype, ␣-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor and has been accepted as a drug for the treatment of cerebrovascular disorders such as cerebral ischemia. Intravenous infusion of zonampanel has been shown to reduce the volume of ischemic damage in rats and cats .The major elimination route of zonampanel is renal excretion in humans (Minematsu et al., 2005). Potential mechanisms by which intravenously administered zonampanel is excreted unchanged into the urine in humans have been identified. The high renal clearance of this drug, approximately 30-fold greater than the product of the glomerular filtration rate (GFR) and the unbound fraction in plasma (f p ), suggests that renal tubular secretion contributes to excretion in the urine (Minematsu et al., 2005). Moreover, zonampanel, which exists as an anion under physiological conditions (pH ϳ7.0 -7.4), is transported by human organic anion transporter (OAT) 1 and OAT3, but not by OAT2 . A recent review article described the expression of transporters in the human proximal renal tubule, including OAT1 and OAT3, on the basolateral membrane (Shitara et al., 2005). Human OAT1 and OAT3 on the basolateral membrane transport zonampanel from the blood into renal proximal tubular cells. Renal tubular secretion is accomplished by membrane transport in two steps: 1) uptake from blood through the basolateral membrane to the proximal tubular cells and 2) excretion from cells to the tubular lumen through the apical membrane. It is therefore likely that zonampanel is rapidly secreted from the blood into the urine via OAT1 and OAT3.Although renal excretion is also the major elimination route of zonampanel in animal species, interspecies differences in the renal/ nonrenal excretion ratio have been observed. After i.v. administration of [14 C]zonampanel to humans, urinary excretion of radioactivity and unchanged zonampanel accounted for 94.9 and 90.6% of the dose, respectively, whereas fecal excretion of radioactivity was only 0.5% (Minematsu et al., 2005